The Pru Brief
Evidence-based insights on peptide therapy, longevity, and the future of health. No noise — just research you can use.
Subscribe to be the first to read it when it drops.
FDA-approved, precisely studied, and built for a specific kind of fat that diet and exercise struggle to reach.
Your pituitary still knows how to make growth hormone. Sermorelin simply reminds it to.
It targets two hormones at once — and the results are unlike anything seen before in obesity medicine.
The science behind the most-discussed drug in a generation — and what it means beyond weight loss.
The differences in how they work, what they do to your body, and why the distinction matters for your health.
Subcutaneous technique, reconstitution, storage, and what to expect — explained plainly and completely.
Your body already makes the molecules that regulate how you age. Here's what researchers are learning about them — and what it could mean for you.
You've probably heard that sleep is important. But the reason goes deeper than most people realize — and it connects directly to peptides.
A careful look at the public figures driving the peptide conversation — what they have said on the record, and how to think about it.
What the 2023 peptide ban was, why it happened, what changed in 2026, and what it means for you.
A plain-English introduction to the molecules at the center of modern personalized medicine.
Don't miss the next issue.
Subscribe to The Pru Brief for evidence-based insights delivered straight to your inbox.